Vimarsana
Biggest News Aggregation in the World

Page 16 - Repligen Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repligen Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repligen Daily Today - Breaking & Trending Today

Repligen Co. (NASDAQ:RGEN) Stock Holdings Lifted by American Capital Management Inc. - Vimarsana News

Repligen Co. (NASDAQ:RGEN) Stock Holdings Lifted by American Capital Management Inc.

American Capital Management Inc. lifted its holdings in Repligen Co. (NASDAQ:RGEN – Get Rating) by 14.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 140,751 shares of the biotechnology company’s stock after buying an additional 17,827 shares during the quarter. American Capital Management Inc. […]

Source: wkrb13.com
The Manufacturers Life Insurance Company Raises Stock Position in Repligen Co. (NASDAQ:RGEN) - Vimarsana News

The Manufacturers Life Insurance Company Raises Stock Position in Repligen Co. (NASDAQ:RGEN)

The Manufacturers Life Insurance Company boosted its position in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 55,557 shares of the biotechnology company’s stock after acquiring an additional 695 shares during the […]

Repligen Co. (NASDAQ:RGEN) Shares Sold by Pitcairn Co. - Vimarsana News

Repligen Co. (NASDAQ:RGEN) Shares Sold by Pitcairn Co.

Pitcairn Co. lowered its stake in Repligen Co. (NASDAQ:RGEN – Get Rating) by 6.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,263 shares of the biotechnology company’s stock after selling 290 shares during the period. Pitcairn Co.’s holdings in Repligen […]

Brokerages Set Repligen Co. (NASDAQ:RGEN) PT at $208.56 - Vimarsana News

Brokerages Set Repligen Co. (NASDAQ:RGEN) PT at $208.56

Shares of Repligen Co. (NASDAQ:RGEN – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have issued a buy rating on the company. The average 12-month target price among […]

StockNews.com Begins Coverage on Repligen (NASDAQ:RGEN) - Vimarsana News

StockNews.com Begins Coverage on Repligen (NASDAQ:RGEN)

StockNews.com assumed coverage on shares of Repligen (NASDAQ:RGEN – Get Rating) in a research note published on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. RGEN has been the topic of several other research reports. Deutsche Bank Aktiengesellschaft cut their price objective on Repligen from $180.00 to $165.00 in a […]